As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Clearmind Medicine Inc. The largest reported stake is Iroquois Capital Management, LLC's, at 9.99%. 15 filings are on record since July 3, 2025 (Schedule 13G/A, August 12, 2026).
Sell to companies like Clearmind Medicine Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Gainor Lewis Berray · Sole voting: 25,300 · Shared voting: 0 · Sole dispositive: 25,300 · Shared dispositive: 0 · SCHEDULE 13G, 2026-10-27
- · Reporting person: Iroquois Capital Management, LLC · Sole voting: 0 · Shared voting: 178,667 · Sole dispositive: 0 · Shared dispositive: 178,667 · SCHEDULE 13G/A, 2026-08-12
- · Holder: Capitalink Ltd. · Percent: 0% · SCHEDULE 13G/A
- · Holder: L.I.A. Pure Capital Ltd. · Percent: 0% · SCHEDULE 13G/A
- · Holder: Capitalink Ltd. · Percent: 5% · SCHEDULE 13G/A
Clearmind Medicine Inc. has 15 Schedule 13D or 13G filings on record since 2025-07-03. 1 holder's latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Iroquois Capital Management, LLC | 9.99% | 178,667 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
| 4.9% | 25,300 | SCHEDULE 13G, 2026-10-27 | 2026-10-20 | |
| AdvisorShares Trust | 4.83% | 205,933 | SCHEDULE 13G/A, 2025-07-03 | 2025-06-30 |
| 0% | 0 | SCHEDULE 13G/A, 2026-03-09 | 2025-12-31 | |
| L.I.A. Pure Capital Ltd. | 0% | 0 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Capitalink Ltd. | 0% | 0 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
Holding shares or following this stake? See who's behind Clearmind Medicine Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Clearmind Medicine Inc. and the records around it.
Clearmind Medicine Inc. elsewhere on the record
Companies that share a holder
- Capitalink Ltd. also filed stake reports on 3 other companies: QUANTUM X LABS INC. (May 2026)
- Nissim Daniel also filed stake reports on 5 other companies: QUANTUM X LABS INC. (Aug 2026)
- AdvisorShares Trust also filed stake reports on 8 other companies: Neuphoria Therapeutics Inc. (Oct 2026), PSYENCE BIOMEDICAL LTD. (Oct 2026), Silo Pharma, Inc. (Jul 2026)
Watch Clearmind Medicine Inc.
Get an email when Clearmind Medicine Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Clearmind Medicine Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Clearmind Medicine Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Clearmind Medicine Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 0 | 178,667 | 0 | 178,667 | SCHEDULE 13G/A, 2026-08-12 |
| Richard Abbe | 168,000 | 178,667 | 168,000 | 178,667 | SCHEDULE 13G/A, 2026-08-12 |
| Kimberly Page | 0 | 178,667 | 0 | 178,667 | SCHEDULE 13G/A, 2026-08-12 |
| Gainor Lewis Berray | 25,300 | 0 | 25,300 | 0 | SCHEDULE 13G, 2026-10-27 |
The latest filing identifies Clearmind Medicine Inc. by CUSIP 185053709 and gives its principal executive office as 101-1220 WEST 6TH AVENUE, VANCOUVER, BRITISH COLUMBIA (SCHEDULE 13G, 2026-10-27).
What the percentages are based on
See Item 11 on the cover pages hereto.Iroquois Capital Management, LLC, SCHEDULE 13G/A, 2026-08-12
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-03 | AdvisorShares Trust | 4.83% | SCHEDULE 13G/A |
| 2025-11-18 | Richard Abbe | 9.94% | SCHEDULE 13G/A |
| 2025-11-28 | Nissim Daniel | 9.99% | SCHEDULE 13G |
| 2025-12-01 | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-01 | Capitalink Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-10 | Capitalink Ltd. | 9.97% | SCHEDULE 13G/A |
| 2025-12-10 | L.I.A. Pure Capital Ltd. | 9.97% | SCHEDULE 13G/A |
| 2026-02-17 | Richard Abbe | 9.99% | SCHEDULE 13G/A |
| 2026-03-09 | Nissim Daniel | 0% | SCHEDULE 13G/A |
| 2026-03-16 | Capitalink Ltd. | 5% | SCHEDULE 13G/A |
| 2026-03-16 | L.I.A. Pure Capital Ltd. | 5% | SCHEDULE 13G/A |
| 2026-05-15 | Capitalink Ltd. | 0% | SCHEDULE 13G/A |
| 2026-05-15 | L.I.A. Pure Capital Ltd. | 0% | SCHEDULE 13G/A |
| 2026-08-12 | Iroquois Capital Management, LLC | 9.99% | SCHEDULE 13G/A |
| 2026-10-27 | Gainor Lewis Berray | 4.9% | SCHEDULE 13G |
Questions about who owns Clearmind Medicine Inc.
Who owns Clearmind Medicine Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Clearmind Medicine Inc.: Iroquois Capital Management, LLC (9.99%, Schedule 13G/A, filed 2026-08-12).
When did Iroquois Capital Management, LLC buy into Clearmind Medicine Inc.?
The filings give report dates, not purchase dates. The earliest filing from Iroquois Capital Management, LLC on this page is the Schedule 13G/A, filed 2026-08-12, reporting 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 15 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Clearmind Medicine Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.